Depression (Major Depressive Disorder): Symptoms, Causes and Complete Treatment Guide
- Dr. Tobias Kohler
- Jul 29
- 8 min read
Depression is one of the most common — and most misunderstood — medical conditions in the United States. In 2025, approximately 18.3% of US adults — an estimated 47.8 million people — currently have depression or are being treated for it, a historic high according to the latest Gallup and CDC data. Young adults aged 18–29 are the hardest hit, with a prevalence rate of 26.7%. Globally, an estimated 280 million people live with depression, according to the World Health Organization.
Despite being highly treatable, the average person with depression waits 11 years between the onset of symptoms and receiving help. Depression is not a character weakness or a failure of willpower — it is a biological medical condition involving measurable changes in brain structure and function, neurotransmitter systems, inflammation, and the stress response.
This complete guide covers what depression actually is, how to recognise its symptoms, what causes it, the different types, and the full evidence-based treatment landscape available in 2025.
The National Institute of Mental Health provides comprehensive depression information at: https://www.nimh.nih.gov/health/topics/depression
If you are experiencing thoughts of suicide or self-harm, call or text the 988 Suicide and Crisis Lifeline at 988 immediately. In a life-threatening situation, call 911.
What is Depression? — Beyond Sadness
Depression — formally Major Depressive Disorder (MDD) — is a clinical syndrome involving persistent low mood or loss of interest that is present for at least 2 weeks, represents a change from previous functioning, and causes significant distress or impairment.
The critical distinction: depression is not ordinary sadness. Everyone experiences sadness, grief, and periods of low mood in response to life events — this is normal and healthy. Depression is distinguished by:
Duration
persisting for weeks or months, not resolving with time or improved circumstances
Pervasiveness
affecting virtually all areas of life, not just responses to specific events
Biological symptoms
sleep disturbance, appetite changes, fatigue, and psychomotor changes that reflect altered brain physiology
Functional impairment
significantly interfering with work, relationships, and self-care
Loss of capacity for pleasure (anhedonia)
the inability to feel enjoyment or interest in previously meaningful activities — one of the most specific diagnostic features
Depression is also a risk factor for suicidal thoughts and behaviours — which is why recognition and treatment are critical.
The Nine Core Symptoms of Major Depression
According to DSM-5 diagnostic criteria, a diagnosis of Major Depressive Disorder requires 5 or more of the following 9 symptoms present during the same 2-week period, with at least one being depressed mood or anhedonia:
Depressed mood
persistent sadness, emptiness, hopelessness, or tearfulness (or irritability in children and adolescents)
Anhedonia
markedly diminished interest or pleasure in all or almost all activities most of the day, nearly every day
Significant weight or appetite change
loss or gain of more than 5% of body weight in a month, or decreased or increased appetite nearly every day
Sleep disturbance
insomnia (difficulty falling or staying asleep, early morning waking) or hypersomnia (excessive sleep) nearly every day
Psychomotor changes
slowing of thoughts and movements observable by others (psychomotor retardation), or restlessness and agitation (psychomotor agitation)
Fatigue or loss of energy
persistent, severe fatigue not explained by physical exertion
Feelings of worthlessness or excessive guilt
not mere self-reproach about being ill, but disproportionate guilt or self-condemnation
Difficulty thinking or concentrating
impaired concentration, attention, and memory; difficulty making decisions
Recurrent thoughts of death or suicidal ideation
passive thoughts about death ("I wish I weren't here"), suicidal ideation with or without a specific plan, or suicide attempts
These symptoms must cause clinically significant distress or functional impairment and must not be attributable to substance use or a medical condition.
Types of Depressive Disorder
Type | Key Features | Duration / Pattern |
Major Depressive Disorder (MDD) | 5+ symptoms for 2+ weeks; significant impairment | Episodic — single or recurrent episodes |
Persistent Depressive Disorder (Dysthymia) | Chronic low-grade depression — fewer symptoms but longer duration | 2+ years continuous |
Seasonal Affective Disorder (SAD) | Depression with seasonal pattern — typically autumn/winter onset, spring remission | Seasonal pattern |
Postpartum Depression | MDD onset within 4 weeks of childbirth (DSM-5) or up to 12 months (clinical practice) | Peripartum onset specifier |
Premenstrual Dysphoric Disorder (PMDD) | Severe mood symptoms in the luteal phase of menstrual cycle | Cyclical with menstrual cycle |
Psychotic Depression | MDD with delusions or hallucinations | Specifier of MDD |
Treatment-Resistant Depression (TRD) | Failure to respond to 2+ adequate antidepressant trials | Ongoing — specialist management |
What Causes Depression?
Depression is not caused by a single factor. It arises from a complex interaction of biological, psychological, and social contributors — the biopsychosocial model:
Biological factors:
Neurotransmitter dysregulation
altered serotonin, noradrenaline, and dopamine signalling in mood-regulating brain circuits. Note: the "chemical imbalance" narrative oversimplifies a more complex picture — neurotransmitter changes are one part of the story
Neuroinflammation
elevated pro-inflammatory cytokines (IL-6, TNF-alpha, CRP) are consistently found in depressed patients. This inflammatory hypothesis explains links between depression and inflammatory conditions (rheumatoid arthritis, psoriasis, inflammatory bowel disease)
HPA axis dysregulation
elevated cortisol from chronic stress response activation; cortisol excess damages the hippocampus (involved in mood regulation and memory)
Genetics
heritability approximately 40–50%; having a first-degree relative with depression approximately doubles lifetime risk
Neuroplasticity
reduced BDNF (brain-derived neurotrophic factor) and reduced hippocampal neurogenesis are found in depression; antidepressants and exercise both increase BDNF
Medical conditions
hypothyroidism, anaemia, Parkinson's disease, chronic pain, cancer, stroke, and many others can cause depression
Psychological factors:
Negative cognitive schemas — persistent patterns of negative thinking about oneself, the world, and the future (Beck's cognitive triad)
History of trauma or adverse childhood experiences (ACEs)
Perfectionism, rumination, and maladaptive coping styles
Learned helplessness
Social factors:
Social isolation and loneliness — 33% of lonely adults have depression vs 13% of non-lonely adults
Financial stress — depression prevalence is 35.1% among low-income adults (<$24K/year) vs approximately 10% in higher earners
Relationship difficulties, bereavement, unemployment
Chronic stress — occupational, caregiving, discrimination-related
Treatment of Depression — The Evidence-Based Approach
Step 1: Accurate Diagnosis
Before treating, it is essential to distinguish unipolar depression (MDD) from bipolar disorder — which includes manic or hypomanic episodes. Antidepressants used alone in bipolar disorder can trigger mania, making accurate diagnosis critical. Medical causes of depression (thyroid dysfunction, anaemia, vitamin B12/D deficiency, sleep apnea) must also be excluded with blood tests.
Step 2: Psychotherapy
Cognitive Behavioural Therapy (CBT) is the gold-standard psychological treatment for depression with the largest evidence base. It achieves remission rates of 40–60% comparable to antidepressants in mild-to-moderate depression, with lower relapse rates.
Other evidence-based therapies include:
Interpersonal Therapy (IPT)
particularly effective for depression linked to grief, role transitions, or interpersonal conflict
Behavioural Activation
focuses on scheduling rewarding activities to counteract the withdrawal and inactivity that maintain depression
Mindfulness-Based Cognitive Therapy (MBCT)
particularly effective for preventing relapse in recurrent depression
Step 3: Antidepressant Medication
For moderate-to-severe depression, medication is recommended — usually alongside psychotherapy:
First-line: SSRIs and SNRIs
SSRIs (Selective Serotonin Reuptake Inhibitors) are first-line pharmacological treatment for depression due to their efficacy, tolerability, and safety profile:
Sertraline (Zoloft) — the most commonly prescribed antidepressant globally; broad evidence base
Escitalopram (Lexapro) — excellent tolerability; often the best-tolerated SSRI
Fluoxetine (Prozac) — long half-life; lowest discontinuation syndrome risk; good for adherence-challenged patients
Paroxetine (Paxil) — effective but higher discontinuation syndrome and anticholinergic side effects
Citalopram (Celexa) — effective; cardiac monitoring recommended at higher doses
SNRIs offer additional noradrenaline reuptake inhibition, potentially helpful when fatigue, concentration, and pain are prominent:
Venlafaxine (Effexor) — broad spectrum; also effective for anxiety
Duloxetine (Cymbalta) — particularly useful when depression coexists with chronic pain
Other important options:
Bupropion (Wellbutrin) — dopamine and noradrenaline reuptake inhibitor; no sexual side effects; helpful when fatigue and low motivation are prominent; also FDA-approved for smoking cessation
Mirtazapine — enhances noradrenaline and serotonin; sedating properties useful when insomnia is prominent; often causes weight gain
Agomelatine — melatonin receptor agonist; available internationally; minimal sexual side effects
Lithium — mood stabiliser used as augmentation in treatment-resistant depression
For Treatment-Resistant Depression:
Esketamine (Spravato)
intranasal ketamine; FDA-approved 2019 for treatment-resistant depression; rapid onset within hours to days
TMS (Transcranial Magnetic Stimulation)
FDA-approved; non-invasive brain stimulation; effective for TRD
ECT (Electroconvulsive Therapy)
the most effective treatment for severe or treatment-resistant depression; modern ECT is delivered under anaesthesia and is safe; profound misconceptions persist about this treatment
Antidepressant Comparison Table
Antidepressant | Class | Best For | Key Side Effects | Sexual SE? |
Sertraline | SSRI | Broad spectrum | GI upset initially | Yes |
Escitalopram | SSRI | Best tolerability | Minimal | Yes |
Fluoxetine | SSRI | Adherence concerns | Activating, insomnia | Yes |
Venlafaxine | SNRI | Depression + anxiety + pain | BP elevation at high dose | Yes |
Duloxetine | SNRI | Depression + chronic pain | Nausea, sweating | Yes |
Bupropion | NDRI | Fatigue, low motivation, smoking | Headache, insomnia | Minimal |
Mirtazapine | NaSSA | Insomnia, low appetite, agitation | Sedation, weight gain | Minimal |
Lithium (augmentation) | Mood stabiliser | TRD augmentation | Tremor, thirst, monitoring | Minimal |
Depression and Physical Health — The Critical Link
Depression has profound physical health consequences that are often underappreciated:
People with depression have a 40% higher risk of developing cardiac disease, hypertension, stroke, diabetes, metabolic syndrome, or obesity than the general population
Depression significantly worsens outcomes in virtually every chronic physical illness
The relationship is bidirectional — physical illness causes depression, and depression worsens physical illness
Treating depression in patients with cardiovascular disease significantly reduces cardiac event rates
For our guide on anxiety disorders — which coexist with depression in approximately 50% of patients: [Anxiety Disorders: Types, Symptoms, Causes and Treatment]
For our guide on sleep disorders — insomnia is both a symptom and cause of depression: [How to Sleep Better: 15 Proven Tips for Insomnia]
For our guide on Generalized Anxiety Disorder — the most common comorbidity with depression: [Generalized Anxiety Disorder: Symptoms, Causes and Treatment]
Detailed depression statistics from NIMH are available at: https://www.nimh.nih.gov/health/statistics/major-depression
The WHO provides global depression context and evidence-based treatment guidance at: https://www.who.int/news-room/fact-sheets/detail/depression
Frequently Asked Questions
How do I know if I have depression or am just sad?
Ordinary sadness is a normal response to difficult life events — it is time-limited, proportionate to the situation, and does not typically prevent you from functioning. Depression involves persistent symptoms lasting at least two weeks, present most of the day nearly every day, that significantly impair daily life. Key features that point toward depression rather than ordinary sadness include anhedonia (inability to feel pleasure in anything), biological symptoms (disrupted sleep, appetite, energy), feelings of worthlessness, and difficulty functioning at work or in relationships.
How long does it take for antidepressants to work?
Most antidepressants take 2 to 6 weeks to produce noticeable mood improvement, with maximum benefit typically at 8 to 12 weeks. Some improvement in sleep and appetite may be noticed in the first 1 to 2 weeks. It is critical not to stop antidepressants in the first 2 to 3 weeks due to perceived lack of effect — the therapeutic window must be reached. If there is no improvement after 4 to 6 weeks at an adequate dose, the dose is typically increased or a different antidepressant tried.
Can depression go away on its own without treatment?
Mild depressive episodes sometimes resolve spontaneously over several months. However, waiting for untreated depression to resolve carries significant risks — it prolongs suffering, increases the risk of recurrence, damages relationships and work performance, and carries a risk of suicidal ideation. Moderate-to-severe depression rarely resolves quickly without treatment. Early intervention with therapy and/or medication produces better short and long-term outcomes than delayed treatment.
Is it safe to stop antidepressants when I feel better?
Do not stop antidepressants without medical guidance. Most guidelines recommend continuing effective antidepressant treatment for at least 6 to 12 months after achieving remission to reduce relapse risk. For patients with recurrent depression (two or more episodes), longer-term or indefinite maintenance treatment is often recommended. Stopping antidepressants abruptly — particularly SSRIs with short half-lives like paroxetine — can cause discontinuation syndrome: dizziness, electric shock sensations, flu-like symptoms, and rebound mood symptoms.
What is the difference between depression and bipolar disorder?
Major Depressive Disorder involves depressive episodes only. Bipolar disorder involves both depressive episodes and manic or hypomanic episodes — periods of elevated or irritable mood, decreased need for sleep, grandiosity, increased goal-directed activity, and impulsive behaviour. The distinction is critical because antidepressants used alone in bipolar disorder can precipitate mania. Anyone presenting with depression should be screened for past hypomanic or manic episodes before starting antidepressants.
Comments